IRIS Accounts Production v24.3.2.46 10101499 Board of Directors 1.5.23 30.4.24 30.4.24 0 0 false true false false true false Ordinary A 0.01000 Ordinary B 500.00000 57381 28125 26325 38856 38857 9600 44849 57381 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh101014992023-04-30101014992024-04-30101014992023-05-012024-04-30101014992022-04-30101014992022-05-012023-04-30101014992023-04-3010101499ns15:EnglandWales2023-05-012024-04-3010101499ns14:PoundSterling2023-05-012024-04-3010101499ns10:Director12023-05-012024-04-3010101499ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3010101499ns10:SmallEntities2023-05-012024-04-3010101499ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3010101499ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3010101499ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3010101499ns10:FullAccounts2023-05-012024-04-3010101499ns10:OrdinaryShareClass12023-05-012024-04-3010101499ns10:OrdinaryShareClass22023-05-012024-04-3010101499ns10:Director2422023-04-3010101499ns10:Director2422022-04-3010101499ns10:Director2422023-05-012024-04-3010101499ns10:Director2422022-05-012023-04-3010101499ns10:Director2422024-04-3010101499ns10:Director2422023-04-3010101499ns10:Director22023-05-012024-04-3010101499ns10:RegisteredOffice2023-05-012024-04-3010101499ns5:CurrentFinancialInstruments2024-04-3010101499ns5:CurrentFinancialInstruments2023-04-3010101499ns5:ShareCapital2024-04-3010101499ns5:ShareCapital2023-04-3010101499ns5:RetainedEarningsAccumulatedLosses2024-04-3010101499ns5:RetainedEarningsAccumulatedLosses2023-04-3010101499ns5:PlantMachinery2023-05-012024-04-3010101499ns5:PlantMachinery2023-04-3010101499ns5:PlantMachinery2024-04-3010101499ns5:PlantMachinery2023-04-3010101499ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-3010101499ns5:WithinOneYearns5:CurrentFinancialInstruments2023-04-3010101499ns10:OrdinaryShareClass12024-04-3010101499ns10:OrdinaryShareClass22024-04-30101014991ns10:Director12023-04-30101014991ns10:Director12022-04-30101014991ns10:Director12023-05-012024-04-30101014991ns10:Director12022-05-012023-04-30101014991ns10:Director12024-04-30101014991ns10:Director12023-04-30
REGISTERED NUMBER: 10101499 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 April 2024

for

Dr Morne Wolmarans Limited
Trading as
Dr Morné Wolmarans Limited

Dr Morne Wolmarans Limited (Registered number: 10101499)
Trading as Dr Morné Wolmarans Limited






Contents of the Financial Statements
for the Year Ended 30 April 2024




Page

Company Information 1

Balance Sheet 2 to 3

Notes to the Financial Statements 4 to 6


Dr Morne Wolmarans Limited
Trading as Dr Morné Wolmarans Limited

Company Information
for the Year Ended 30 April 2024







DIRECTORS: Ms T Welch
Mr M R Wolmarans





REGISTERED OFFICE: Suite 1
Concept House
23 Billet Lane
Hornchurch
Essex
RM11 1XP





REGISTERED NUMBER: 10101499 (England and Wales)





ACCOUNTANTS: Havard & Associates
Suite 1
Concept House
23 Billet Lane
Hornchurch
Essex
RM11 1XP

Dr Morne Wolmarans Limited (Registered number: 10101499)
Trading as Dr Morné Wolmarans Limited

Balance Sheet
30 April 2024

30.4.24 30.4.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 46,238 8,107

CURRENT ASSETS
Debtors 5 60,813 78,310
Cash at bank 30,162 30,773
90,975 109,083
CREDITORS
Amounts falling due within one year 6 41,599 43,814
NET CURRENT ASSETS 49,376 65,269
TOTAL ASSETS LESS CURRENT
LIABILITIES

95,614

73,376

PROVISIONS FOR LIABILITIES 1,921 1,540
NET ASSETS 93,693 71,836

CAPITAL AND RESERVES
Called up share capital 7 1,001 1,001
Retained earnings 92,692 70,835
SHAREHOLDERS' FUNDS 93,693 71,836

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Dr Morne Wolmarans Limited (Registered number: 10101499)
Trading as Dr Morné Wolmarans Limited

Balance Sheet - continued
30 April 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 7 February 2025 and were signed on its behalf by:





Mr M R Wolmarans - Director


Dr Morne Wolmarans Limited (Registered number: 10101499)
Trading as Dr Morné Wolmarans Limited

Notes to the Financial Statements
for the Year Ended 30 April 2024

1. STATUTORY INFORMATION

Dr Morne Wolmarans Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost and 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

Dr Morne Wolmarans Limited (Registered number: 10101499)
Trading as Dr Morné Wolmarans Limited

Notes to the Financial Statements - continued
for the Year Ended 30 April 2024

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 May 2023 15,294
Additions 40,669
Disposals (5,764 )
At 30 April 2024 50,199
DEPRECIATION
At 1 May 2023 7,187
Charge for year 1,730
Eliminated on disposal (4,956 )
At 30 April 2024 3,961
NET BOOK VALUE
At 30 April 2024 46,238
At 30 April 2023 8,107

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.24 30.4.23
£    £   
Trade debtors 9,711 14,674
Other debtors 51,102 63,636
60,813 78,310

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.24 30.4.23
£    £   
Bank loans and overdrafts - 1
Trade creditors 1,500 -
Taxation and social security 38,539 42,312
Other creditors 1,560 1,501
41,599 43,814

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.4.24 30.4.23
value: £    £   
100 Ordinary A 1p 1 1
2 Ordinary B £500 1,000 1,000
1,001 1,001

Dr Morne Wolmarans Limited (Registered number: 10101499)
Trading as Dr Morné Wolmarans Limited

Notes to the Financial Statements - continued
for the Year Ended 30 April 2024

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 30 April 2024 and 30 April 2023:

30.4.24 30.4.23
£    £   
Mr M R Wolmarans and Ms T Welch
Balance outstanding at start of year 57,381 28,125
Amounts advanced 26,325 38,856
Amounts repaid (38,857 ) (9,600 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 44,849 57,381

Interest on the above loan has been charged at 2.5%.